macro

BAS lifts 2026 EBITDA guidance after third-quarter sales growth

BAS reported third-quarter sales up 14.2% and adjusted EBITDA up 14.9%. Its 2026 EBITDA guidance was raised to €7.4–€7.8 billion, per TradingView.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

what happened

According to TradingView, BAS posted third-quarter sales growth of 14.2% and a 14.9% rise in adjusted EBITDA before special items. Reported EBIT turned negative, however, due to impairments and special costs.

The company increased its 2026 EBITDA guidance to a range of €7.4 to €7.8 billion. The TradingView item is an AI-generated summary, so key figures should be checked against the original source.

why it matters

A higher EBITDA outlook suggests operating profit is growing and that management sees continued momentum in the business. The negative EBIT, driven by write-downs, shows that one-off charges still weigh heavily on the bottom line and may temper investor reaction to the report.

market impact

BAS shares: the higher EBITDA outlook supports earnings expectations for the company

  • BAS shares pressure up — the higher EBITDA outlook supports earnings expectations

tags

instruments

BASЕвропейские акции химииEUR/USD

sources

  1. BAS: Higher Q3 sales and adjusted EBITDA; FY2026 EBITDA guidance raised — TradingView, 28 October 2026 at 06:13 UTC
  2. BAS: Higher Q3 sales and adjusted EBITDA lifted guidance despite weakness in two segments — TradingView, 28 October 2026 at 06:13 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗